(Q43940364)

28 November 2017

title

Frequency of the SLCO1B1 388A>G and the 521T>C polymorphism in Tanzania genotyped by a new LightCycler®-based method (English)

1 reference

28 November 2017

0 references

1

1 reference

28 November 2017

7

1 reference

28 November 2017

8

1 reference

28 November 2017

Victoria Ziesenitz

6

0 references

author name string

Sabina Mugusi

2

1 reference

28 November 2017

Eliford Ngaimisi

3

1 reference

28 November 2017

Michael Marcus Hoffmann

4

1 reference

28 November 2017

Sonja König

5

1 reference

28 November 2017

Johanna Weiss

9

1 reference

28 November 2017

publication date

1 June 2011

1 reference

European Journal of Clinical Pharmacology

28 November 2017

published in

1 reference

28 November 2017

volume

67

1 reference

28 November 2017

issue

11

1 reference

28 November 2017

page(s)

1139-1145

1 reference

Effects of tuberculosis, race, and human gene SLCO1B1 polymorphisms on rifampin concentrations

28 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1065-9

Effect of OATP1B1 (SLCO1B1) variant alleles on the pharmacokinetics of pitavastatin in healthy volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1065-9

Effect of SLCO1B1 polymorphism on the plasma concentrations of bile acids and bile acid synthesis marker in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1065-9

Bosentan is a substrate of human OATP1B1 and OATP1B3: inhibition of hepatic uptake as the common mechanism of its interactions with cyclosporin A, rifampicin, and sildenafil

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1065-9

HIV protease inhibitors are substrates for OATP1A2, OATP1B1 and OATP1B3 and lopinavir plasma concentrations are influenced by SLCO1B1 polymorphisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1065-9

Hepatic OATP and OCT uptake transporters: their role for drug-drug interactions and pharmacogenetic aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1065-9

Comparison of SLCO1B1 sequence variability among German, Turkish, and African populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1065-9

Disposition of ezetimibe is influenced by polymorphisms of the hepatic uptake carrier OATP1B1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1065-9

Enterohepatic bile salt transporters in normal physiology and liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1065-9

Polymorphisms of OATP-C (SLC21A6) and OAT3 (SLC22A8) genes: consequences for pravastatin pharmacokinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1065-9

Human organic anion transporting polypeptide-C (SLC21A6) is a major determinant of rifampin-mediated pregnane X receptor activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1065-9

High plasma pravastatin concentrations are associated with single nucleotide polymorphisms and haplotypes of organic anion transporting polypeptide-C (OATP-C, SLCO1B1)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1065-9

Effect of drug transporter genotypes on pravastatin disposition in European- and African-American participants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1065-9

SLCO1B1 (OATP1B1, an uptake transporter) and ABCG2 (BCRP, an efflux transporter) variant alleles and pharmacokinetics of pitavastatin in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1065-9

Influence of OATP1B1 genotype on the pharmacokinetics of rosuvastatin in Koreans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1065-9

Fexofenadine pharmacokinetics are associated with a polymorphism of the SLCO1B1 gene (encoding OATP1B1)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1065-9

Influence of the organic anion-transporting polypeptide 1B1 (OATP1B1) polymorphisms on irinotecan-pharmacokinetics and clinical outcome of patients with advanced non-small cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1065-9

Different effects of SLCO1B1 polymorphism on the pharmacokinetics and pharmacodynamics of repaglinide and nateglinide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1065-9

The impact of SLCO1B1 polymorphisms on the plasma concentration of lopinavir and ritonavir in HIV-infected men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1065-9

Rapid genotyping of the OATP1B1 polymorphisms A388G and T521C with real-time PCR FRET assays.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1065-9

Polymorphisms in OATP-C: identification of multiple allelic variants associated with altered transport activity among European- and African-Americans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1065-9

Rapid identification of three functionally relevant polymorphisms in the OATP1B1 transporter gene using Pyrosequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1065-9

Pharmacogenetics of SLCO1B1: haplotypes, htSNPs and hepatic expression in three distinct Asian populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1065-9

Long-term efavirenz autoinduction and its effect on plasma exposure in HIV patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1065-9

A novel polymorphism in ABCB1 gene, CYP2B6*6 and sex predict single-dose efavirenz population pharmacokinetics in Ugandans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1065-9

OATP1B1 POLYMORPHISM IS A MAJOR DETERMINANT OF SERUM BILIRUBIN LEVEL BUT NOT ASSOCIATED WITH RIFAMPICIN-MEDIATED BILIRUBIN ELEVATION

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1065-9

Evidence for inverse effects of OATP-C (SLC21A6) 5 and 1b haplotypes on pravastatin kinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1065-9

Organic anion transporting polypeptide 1B1: a genetically polymorphic transporter of major importance for hepatic drug uptake

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1065-9

SLCO1B1 variants and statin-induced myopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1065-9

Global analysis of genetic variation in SLCO1B1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1065-9

SLCO1B1 polymorphism markedly affects the pharmacokinetics of simvastatin acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1065-9

SLCO1B1 polymorphism and sex affect the pharmacokinetics of pravastatin but not fluvastatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1065-9

Different Effects of SLCO1B1 Polymorphism on the Pharmacokinetics of Atorvastatin and Rosuvastatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1065-9

Frequencies of single nucleotide polymorphisms and haplotypes of organic anion transporting polypeptide 1B1 SLCO1B1 gene in a Finnish population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1065-9

Pharmacogenetics of SLCO1B1 gene and the impact of *1b and *15 haplotypes on irinotecan disposition in Asian cancer patients

21 January 2018

1 reference

12 December 2020

Duplex pyrosequencing assay of the 388A>G and 521T>C SLCO1B1 polymorphisms in three Asian populations

1 reference

12 December 2020

OATP and P-glycoprotein transporters mediate the cellular uptake and excretion of fexofenadine

1 reference

12 December 2020

Effects of organic anion transporting polypeptide 1B1 haplotype on pharmacokinetics of pravastatin, valsartan, and temocapril

1 reference

12 December 2020

10.1007/S00228-011-1065-9

Identifiers

DOI

1 reference

28 November 2017

1 reference